Adagene Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Adagene Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Jiangsu
- Headquarters country
- China
- Fiscal year end
- December
- Ticker symbol
- ADAG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001818838
Board of directors
-
Andy Yiu Leung Cheung · DirectorSince 2026
-
Cuong Do V · DirectorSince 2026
-
Li Zhu · DirectorSince 2026
-
Man Kin Tam · Director · Chief Financial OfficerSince 2026
-
Peter Luo · Director · Chief Executive OfficerSince 2026
-
Ulf Grawunder · DirectorSince 2026
Chief executives
Peter Luo
· Chief Executive Officer
Since March 2026
Board connections
1 of this board's directors also sit on 2 other boards.
- via Cuong Do V
- via Cuong Do V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $162,244
- 5 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Man Kin Tam Director, Officer (Chief Financial Officer) | Open-market purchase | +2,000 | $3.00 | $6,000 |
| Sep 16, 2026 | Peter Luo Director, Officer (Chief Executive Officer) | Open-market purchase | +20,290 | $3.15 | $63,980 |
| Aug 14, 2026 | Cuong Do V Director | Open-market purchase | +2,000 | $3.75 | $7,500 |
| Aug 5, 2026 | Peter Luo Director, Officer (Chief Executive Officer) | Open-market purchase | +279 | $3.65 | $1,018 |
| Aug 4, 2026 | Peter Luo Director, Officer (Chief Executive Officer) | Open-market purchase | +22,966 | $3.65 | $83,746 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.